Trending Now
Kintara Therapeutics Inc. (NASDAQ: KTRA) Releases Topline Data from Open-Label GBM...
Kintara Therapeutics Inc. (NASDAQ: KTRA) has announced topline data from its newly-diagnosed adjuvant arm of the open-label second phase clinical trial being carried at the...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Sports Stocks Approach Breakout Potential (CHDN, WWE, BTDG, MSGS)
The live sports space has been a key story in the process of the pandemic. Now, with multiple vaccine candidates moving toward emergency use...
MAKE IT MODERN
LATEST REVIEWS
The USPTO Grants An Innovative Composition Of Matter Patent To Alterity...
Alterity Therapeutics Ltd (NASDAQ: ATHE) received a new patent from the USPTO (The United States Patent and Trademark Office).
With this new patent, Alterity can...
MAKE IT MODERN
PERFORMANCE TRAINING
Oncolytics Biotech, Inc. (NASDAQ:ONCY) Commences TNBC Study To Investigate The Use Of Pelareorep Along...
Oncolytics Biotech, Inc. (NASDAQ:ONCY) begins TNBC (triple-negative breast cancer) study, which is sponsored by the investigator. New Jersey-based Rutgers Cancer Institute (RCI) will manage...
A Spoonful of Sugarmade Inc (OTCMKTS:SGMD)?
Every industry goes through an evolutionary process. It’s path-dependent in many ways, and you know conceptual factors, at least analogically. Cannabis is no different....
NantKwest Inc. (NASDAQ:NK) And ImmunityBio Add Cohort 3 In Phase 2 Pancreatic Cancer Study...
NantKwest Inc. (NASDAQ:NK) has announced the addition of a third cohort to its ongoing Phase 2 study if its novel immunotherapy for the treatment...
Jaguar Health Inc. (NASDAQ:JAGX) Subsidiary Napo Pharmaceuticals Announces the Filing of New Drug Application
Covid-19 has touched everyone across the globe because if you are not infected, you are affected. People and businesses are becoming helpless and distressed...
CNS Pharmaceuticals Inc. (NASDAQ:CNSP) Announces its Plans for its Lead Product Candidate, Berubicin
CNS Pharmaceuticals Inc. (NASDAQ:CNSP) has its lead product candidate, Berubicin being studied for the treatment of glioblastoma multiforme (GBM). A couple of months ago,...
MAKE IT MODERN
